Luis
Montuenga Badía
Catedrático de Universidad
Publicaciones (256) Publicaciones de Luis Montuenga Badía
2024
-
Elevated expression of complement factor I in lung cancer cells associates with shorter survival–Potentially via non-canonical mechanism
Translational Research, Vol. 269, pp. 1-13
-
Lung Cancer Screening in People With COPD: The Pamplona-IELCAP Experience
Archivos de Bronconeumologia, Vol. 60, Núm. 2, pp. 95-100
-
Oxidative Damage and Telomere Length as Markers of Lung Cancer Development among Chronic Obstructive Pulmonary Disease (COPD) Smokers
Antioxidants, Vol. 13, Núm. 2, pp. 156
-
Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b; ≤20 mm) NSCLC Treated by Stereotactic Body Radiation Therapy and Surgery
Journal of Thoracic Oncology, Vol. 19, Núm. 3, pp. 476-490
-
Protein Biomarkers in Lung Cancer Screening: Technical Considerations and Feasibility Assessment
Archivos de Bronconeumologia
-
Ultrasensitive immunosensor for multiplex detection of cancer biomarkers carcinoembryonic antigen (CEA) and yamaguchi sarcoma viral oncogene homolog 1 (YES1) based on eco-friendly synthesized gold nanoparticles
Talanta, Vol. 266
-
Whole exome sequencing and machine learning germline analysis of individuals presenting with extreme phenotypes of high and low risk of developing tobacco-associated lung adenocarcinoma
eBioMedicine, Vol. 102
2023
-
Cancer Cell-Intrinsic Alterations Associated with an Immunosuppressive Tumor Microenvironment and Resistance to Immunotherapy in Lung Cancer
Cancers, Vol. 15, Núm. 12
-
Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program
Annals of Epidemiology, Vol. 77, pp. 1-12
-
Development of electrochemical immunosensor for quantitative detection of non-small cell lung cancer (NSCLC) biomaker YES1
Biosensors and Bioelectronics: X, Vol. 14
-
El citoesqueleto
Biología celular biomédica (Elsevier), pp. 268-300
-
Estrogen Receptor and Immune Checkpoint Inhibitors: New Partners in Lung Cancer?
Clinical cancer research : an official journal of the American Association for Cancer Research
-
IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer
Journal of Thoracic Oncology, Vol. 18, Núm. 5, pp. 564-575
-
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, Vol. 29, Núm. 10, pp. 1100-1108
-
PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
Cancer Research, Vol. 83, Núm. 15, pp. 2513-2526
-
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer
EMBO Reports, Vol. 24, Núm. 8
2022
-
Characterization of the spectrum of trivalent VAV1-mutation-driven tumours using a gene-edited mouse model
Molecular Oncology, Vol. 16, Núm. 19, pp. 3533-3553
-
Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis
Cancer Letters, Vol. 529, pp. 70-84
-
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity
The Journal of experimental medicine, Vol. 219, Núm. 12
-
Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System
Cancers, Vol. 14, Núm. 11